• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DRExplainer:基于有向图卷积网络的药物反应预测中的可量化可解释性。

DRExplainer: Quantifiable interpretability in drug response prediction with directed graph convolutional network.

作者信息

Shi Haoyuan, Xu Tao, Li Xiaodi, Gao Qian, Xiong Zhiwei, Xia Junfeng, Yue Zhenyu

机构信息

University of Science and Technology of China, Hefei, 230026, Anhui, China; School of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, 230036, Anhui, China.

School of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, 230036, Anhui, China.

出版信息

Artif Intell Med. 2025 May;163:103101. doi: 10.1016/j.artmed.2025.103101. Epub 2025 Mar 4.

DOI:10.1016/j.artmed.2025.103101
PMID:40056540
Abstract

Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological entities and predicting the directional response remain major challenges. Here, we propose a novel interpretable predictive model, DRExplainer, which leverages a directed graph convolutional network to enhance the prediction in a directed bipartite network framework. DRExplainer constructs a directed bipartite network integrating multi-omics profiles of cell lines, the chemical structure of drugs and known drug response to achieve directed prediction. Then, DRExplainer identifies the most relevant subgraph to each prediction in this directed bipartite network by learning a mask, facilitating critical medical decision-making. Additionally, we introduce a quantifiable method for model interpretability that leverages a ground truth benchmark dataset curated from biological features. In computational experiments, DRExplainer outperforms state-of-the-art predictive methods and another graph-based explanation method under the same experimental setting. Finally, the case studies further validate the interpretability and the effectiveness of DRExplainer in predictive novel drug response. Our code is available at: https://github.com/vshy-dream/DRExplainer.

摘要

预测癌细胞系对治疗药物的反应对于个性化医疗至关重要。尽管已经开发了许多用于药物反应预测的深度学习方法,但整合有关生物实体的各种信息并预测定向反应仍然是主要挑战。在此,我们提出了一种新颖的可解释预测模型DRExplainer,它在有向二分网络框架中利用有向图卷积网络来增强预测。DRExplainer构建了一个有向二分网络,整合细胞系的多组学特征、药物的化学结构和已知的药物反应,以实现定向预测。然后,DRExplainer通过学习一个掩码来识别该有向二分网络中与每个预测最相关的子图,促进关键的医疗决策。此外,我们引入了一种基于从生物学特征策划的真实基准数据集的模型可解释性量化方法。在计算实验中,在相同实验设置下,DRExplainer优于现有最先进的预测方法和另一种基于图的解释方法。最后,案例研究进一步验证了DRExplainer在预测新型药物反应方面的可解释性和有效性。我们的代码可在以下网址获取:https://github.com/vshy-dream/DRExplainer。

相似文献

1
DRExplainer: Quantifiable interpretability in drug response prediction with directed graph convolutional network.DRExplainer:基于有向图卷积网络的药物反应预测中的可量化可解释性。
Artif Intell Med. 2025 May;163:103101. doi: 10.1016/j.artmed.2025.103101. Epub 2025 Mar 4.
2
Interpretable Dynamic Directed Graph Convolutional Network for Multi-Relational Prediction of Missense Mutation and Drug Response.用于错义突变和药物反应多关系预测的可解释动态有向图卷积网络
IEEE J Biomed Health Inform. 2025 Feb;29(2):1514-1524. doi: 10.1109/JBHI.2024.3483316. Epub 2025 Feb 10.
3
Integration of autoencoder and graph convolutional network for predicting breast cancer drug response.基于自动编码器和图卷积网络的乳腺癌药物反应预测
J Bioinform Comput Biol. 2024 Jun;22(3):2450013. doi: 10.1142/S0219720024500136.
4
Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer.利用晚期癌症患者腹部和骨盆 CT 图像建立卷积神经网络模型预测股骨近端病理性骨折的研究
Clin Orthop Relat Res. 2023 Nov 1;481(11):2247-2256. doi: 10.1097/CORR.0000000000002771. Epub 2023 Aug 23.
5
iACP-DPNet: a dual-pooling causal dilated convolutional network for interpretable anticancer peptide identification.iACP-DPNet:一种用于可解释抗癌肽识别的双池因果扩张卷积网络。
Funct Integr Genomics. 2025 Jul 4;25(1):147. doi: 10.1007/s10142-025-01641-x.
6
MO-GCAN: multi-omics integration based on graph convolutional and attention networks.MO-GCAN:基于图卷积和注意力网络的多组学整合
Bioinformatics. 2025 Aug 2;41(8). doi: 10.1093/bioinformatics/btaf405.
7
SAGCN: Using Graph Convolutional Network With Subgraph-Aware for circRNA-Drug Sensitivity Identification.SAGCN:使用具有子图感知能力的图卷积网络进行环状RNA-药物敏感性识别。
IEEE/ACM Trans Comput Biol Bioinform. 2024 Nov-Dec;21(6):1765-1774. doi: 10.1109/TCBB.2024.3415058. Epub 2024 Dec 10.
8
Multi-view based heterogeneous graph contrastive learning for drug-target interaction prediction.基于多视图的异构图对比学习用于药物-靶点相互作用预测
J Biomed Inform. 2025 Aug;168:104852. doi: 10.1016/j.jbi.2025.104852. Epub 2025 Jun 2.
9
The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.多组学融合预测药物敏感性揭示了泛癌中药物反应的异质性。
Comput Biol Med. 2023 Sep;163:107220. doi: 10.1016/j.compbiomed.2023.107220. Epub 2023 Jul 1.
10
Geometric graph neural networks on multi-omics data to predict cancer survival outcomes.基于多组学数据的几何图神经网络预测癌症生存结局
Comput Biol Med. 2023 Sep;163:107117. doi: 10.1016/j.compbiomed.2023.107117. Epub 2023 Jun 9.